Pancreaticoduodenectomy after neoadjuvant therapy in a Jehovah's Witness with locally advanced pancreatic cancer: Case report and approach to avoid transfusion

David Magner, James R. Ouellette, Joseph R. Lee, Steven D Colquhoun, Simon Lo, Nicholas N. Nissen

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

Although the morbidity and mortality rates associated with pancreaticoduodenectomy (PD) have been improving over the past several decades, perioperative transfusions are often needed. Here, we review the preoperative planning and overall management of a Jehovah's Witness patient with locally advanced pancreatic cancer who would not accept blood transfusion. Management of this case is reviewed, along with the relevant literature regarding major surgery in the Jehovah's Witness population. The use of neoadjuvant chemoradiation was used successfully in locally advanced disease, allowing surgical resection. In addition, we outline a cogent strategy using pre-, intra-, and postoperative techniques to minimize blood loss and maintain hemoglobin at acceptable levels thereby preventing the need for transfusion. These strategies, once in place, may be able to reduce transfusions in all patients having major resections for malignancy.

Original languageEnglish (US)
Pages (from-to)435-437
Number of pages3
JournalAmerican Surgeon
Volume72
Issue number5
StatePublished - Dec 1 2006
Externally publishedYes

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Pancreaticoduodenectomy after neoadjuvant therapy in a Jehovah's Witness with locally advanced pancreatic cancer: Case report and approach to avoid transfusion'. Together they form a unique fingerprint.

  • Cite this